Ranivisio 유럽 연합 - 폴란드어 - EMA (European Medicines Agency)

ranivisio

midas pharma gmbh - ranibizumab - wet macular degeneration; macular edema; diabetic retinopathy; diabetes complications - okulistyka - ranivisio is indicated in adults for:• the treatment of neovascular (wet) age-related macular degeneration (amd)• the treatment of visual impairment due to diabetic macular oedema (dme)• the treatment of proliferative diabetic retinopathy (pdr)• the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo)• the treatment of visual impairment due to choroidal neovascularisation (cnv).

Midas Duo 250 EC 폴란드 - 폴란드어 - Ministerstwo Rolnictwa i Rozwoju Wsi

midas duo 250 ec

rudnikagro sp. z o.o. ul. pomorska, 70-812 - trineksapak etylu - 250 g - regulator wzrostu